Hyperfine is looking to head to public markets with the lofty goal of disrupting the magnetic resonance imaging (MRI) market with the first portable MRI machine approved by the Food and Drug Administration. In this episode of Industry Focus: Wildcard, join Brian Feroldi and Emily Flippen as they break down Hyperfine's road show and unpack this recent target for a special purpose acquisition company (SPAC). To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting